K2M gaining foothold on complex spinal deformity market: 4 insights

Written by Megan Wood | April 11, 2016 | Print  |

Leesburg, Va.-based K2M continues to make a splash in the spine market, according to Seeking Alpha.

Here are four insights:

 

1. K2M has positioned itself as a strong competitor in the complex spinal deformity market.

 

2. The company has disrupted the scoliosis market, offering products that are less invasive and more convenient.

 

3. In 2015, K2M received 15 FDA approvals and launched numerous new products including Cascade, Everest, Mesa 2 and Capri corpectomy cages.

 

4. Although the company's shares seem undervalued, K2M is small and the new products may drive growth in 2016.

 

More articles on devices:
RTI Surgical launches Streamline TL Spinal Fixation System with new capabilities — 4 highlights
Bodycad introduces Bodycad OnCall for personalized restoration evaluation process — 5 takeaways
Emerging medical device companies find help in AcceLinx's new program — 4 takeaways

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months